American Society of Clinical Oncology

SHERPA: White

People

  1. Schoder
    Schoder
  2. Scher
    Scher
  3. Slovin
    Slovin
  4. Autio
    Autio
  5. Brennan
    Brennan
  6. Capanu
    Capanu
  7. Coit
    Coit
  8. Fox
    Fox
  9. Humm
    Humm
  10. Ilson
    Ilson

Groups

  1. Department of Medicine (6)
  2. Molecular Imaging and Therapy Service (6)
  3. Radiology, Department of (6)
  4. Solid Tumor Oncology Division (6)
  5. Molecular Pharmacology and Chemistry Program Faculty (5)
  6. Sloan Kettering Institute Faculty (5)
  7. Center for Pancreatic Cancer Research (4)
  8. GSK Faculty (4)
  9. Genitourinary Oncology Service (4)
  10. Hematologic Malignancies, Division of (4)
Search Within
  1. "2013"
  2. "Heiko Schoder"
Formats
  1. Meeting Abstract (6)
Groups
  1. Department of Medicine (6)
  2. Molecular Imaging and Therapy Service (6)
  3. Radiology, Department of (6)
  4. Solid Tumor Oncology Division (6)
  5. Molecular Pharmacology and Chemistry Program Faculty (5)
  6. Sloan Kettering Institute Faculty (5)

More Groups

People
  1. Heiko Schoder (6)
  2. Howard Scher (4)
  3. Susan Slovin (3)
  4. Dana Rathkopf (2)
  5. Daniel Coit (2)
  6. David Ilson (2)

More People

Years
  1. 2013 (6)
Publications
  1. Journal of Clinical Oncology (6)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of preoperative chemotherapy plus bevacizumab with early salvage therapy based on FDG-PET response in patients with locally advanced gastric and GEJ adenocarcinoma
    Meeting Abstract

    Won, E.; Ilson, D.; Kelsen, D. P.; Strong, V. E.; Schoder, H.; Janjigian, Y. Y.; Shah, M. A.; Coit, D. G.; Brennan, M. F.; Capanu, M.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Chimeric antigen receptor (CAR(+)) modified T cells targeting prostate-specific membrane antigen (PSMA) in patients (pts) with castrate metastatic prostate cancer (CMPC)
    Meeting Abstract

    Slovin, S. F.; Wang, X.; Hullings, M.; Arauz, G.; Bartido, S.; Lewis, J. S.; Schoder, H.; Zanzonico, P.; Scher, H. I.; Sadelain, M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Chimeric antigen receptor (CAR(+)) modified T cells targeting prostate specific membrane antigen (PSMA) in patients (pts) with castrate metastatic prostate cancer (CMPC)
    Meeting Abstract

    Slovin, S. F.; Wang, X.; Hullings, M.; Arauz, G.; Bartido, S.; Lewis, J. S.; Schoder, H.; Zanzonico, P.; Scher, H. I.; Riviere, I.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Preoperative chemotherapy plus bevacizumab with early salvage therapy based on FDG-PET response in locally advanced gastroesophageal junction and gastric adenocarcinoma
    Meeting Abstract

    Ku, G. Y.; Kelsen, D. P.; Strong, V. E.; Schöder, H.; Janjigian, Y. Y.; Shah, M. A.; Coit, D. G.; Brennan, M. F.; Capanu, M.; Ilson, D. H.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Post-treatment alterations in 18F-dihydrotestosterone (FDHT) and FDG PET/CT in metastatic castration-resistant prostate cancer (mCRPC) treated with cabozantinib
    Meeting Abstract

    Fox, J. J.; Haupt, E. C.; Humm, J.; Autio, K. A.; Rathkopf, D. E.; Vargas, H. A.; Schöder, H.; Hricak, H.; Larson, S. M.; Scher, H. I.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Evaluating 18F-16B-fluoro-5α-dihydrotestosterone (FDHT) and FDG-PET as a measure of disease progression in metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Autio, K. A.; Fox, J. J.; Schneider, C. W.; Schöder, H.; Humm, J.; Rathkopf, D. E.; Slovin, S. F.; Danila, D. C.; Haupt, E. C.; Larson, S. M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save